Review uncovers senescence mechanisms and senotherapeutic targets in oral cancer microenvironments, suggesting novel translational strategies to improve clinical outcomes.
Cellular senescence, characterized by stable cell cycle arrest, plays a multifaceted role in the development of oral cancer, attracting growing attention for its influence on cancer progression and therapeutic approaches. The accumulation of senescent cells in the oral microenvironment, especially with aging, may contribute to intrinsic vulnerability to oral cancer. This review examines the mechanisms connecting senescence to oral cancer, with a focus on DNA damage, inflammation, and epigenetic alterations. Additionally, we discuss emerging therapeutic approaches targeting senescent cells, including senolytics, senomorphics, and immune-based strategies, along with their potential translational applications in oral cancer therapy. Given the complex interplay between senescent cells and the tumor microenvironment, these therapeutic translational strategies hold promise for enhancing patient outcomes.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: